Leo H. Evart, Inc.
Source: SEC Form 13F · as of Mar 2026Leo H. Evart, Inc. holds 20 biotech & pharma companies tracked by BioSniper, totaling $2.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$2.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 1,890 | $462K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,364 | $369K |
| LLYELI LILLY & Co | 332 | $305K |
| ABBVAbbVie Inc. | 1,144 | $249K |
| PMPhilip Morris International Inc | 1,154 | $191K |
| ABTABBOTT LABORATORIES | 1,616 | $166K |
| AMGNAMGEN INC | 332 | $117K |
| GILDGILEAD SCIENCES, INC. | 534 | $74K |
| PFEPFIZER INC | 1,798 | $50K |
| GEHCGE HealthCare Technologies Inc. | 196 | $14K |
| GMOptec International, Inc. | 104 | $8K |
| NVONovo Nordisk A/S | 78 | $3K |
| PRGOPERRIGO Co plc | 142 | $2K |
| TLRYTilray Brands, Inc. | 200 | $1K |
| EVOEvotec SE | 456 | $1K |
| VTRSViatris Inc | 70 | $946 |
| CRSPCRISPR Therapeutics AG | 10 | $476 |
| PRTAPROTHENA CORP PUBLIC LTD CO | 44 | $428 |
| RMTIROCKWELL MEDICAL, INC. | 18 | $16 |
| SKYESkye Bioscience, Inc. | 2 | $2 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.